Flies with colon cancer help to unravel the genetic keys to disease in humans

Flies with colon cancer help to unravel the genetic keys to disease in humans
In green, details of a tumor are surrounded by the muscle fibers (red) of Drosophila. Credit: O Martorell, IRB Barcelona

Researchers at the Institute for Research in Biomedicine (IRB Barcelona) have managed to generate a fruit fly (Drosophila melanogaster) model that reproduces human colon cancer. With two publications appearing in PLoS One and EMBO Reports, the IRB team also unveil the function of a key gene in the development of the disease.

"The breakthrough is that we have generated in an adult organism and from , thus reproducing what happens in most types of . This model has allowed us to identify subtle interactions in the development of cancer that are practically impossible to detect in mice with the current technology available," explains the biologist Andreu Casali, Associate Researcher at IRB Barcelona and leader of the Drosophila project.

Although the flies do not have a colon, they have an intestine that includes a colon and rectum and that works in the same way as the human colon. The scientists generated for two genes that are altered in most human colon tumours, namely APC and Ras. Thanks to the ease with which genetic studies can be performed in Drosophila, the researchers were able to examine the effect of 250 genes that are altered in these types of tumour and found that, of these, 30% affected growth while the others had no significant effects.

"The advantage of the model is that it allows us to explore genetic alterations more quickly, to distinguish between those that are important and those that are not, and to see what role they play," explains Òscar Martorell, first author of the paper that appears in EMBO Reports published today. "Performing these genetic experiments in mice is time-consuming and costly and the Drosophila model allows us to rapidly analyse new pathways that could be relevant for colon cancer," adds the co-author of the study, Francisco Barriga, a postdoctoral fellow working on in vertebrate models. Undertaken over five years, the study is the result of collaboration between the Development and Morphogenesis in Drosophila Lab and the Colorectal Cancer Lab, both at IRB Barcelona.

Of all the genes that have a relevant function, the group focused on one called Mirror in Drosophila and lrx in humans. The experiments with flies led to the finding that this gene favours tumour growth in early stages of human cancer. "The problem with human cancer is that we know very little about what happens in the early stages. Our models allows us to better study its development." Also, Casali goes on to speculate that the human gene lrx may become a good drug target "for example, to prevent benign adenomas from developing further." However, first the validity of the gene as a therapeutic target has to be tested in mice.

Flies with colon cancer help to unravel the genetic keys to disease in humans
The tumor growth in the intestine of an adult fly is shown in green. Credit: O Martorell, IRB Barcelona

A good in vivo guinea pig for drugs

The researchers also expound that flies can be used to study candidate drug molecules to combat cancer. Drosophila would serve as an intermediate step between the in vitro phase and testing in vertebrates. On the one hand, this model has the in vitro advantages because many molecules can be tested at a minimum dose, and on the other, it shares the advantage of animals models because, as it is a living organism, toxic molecules or those with poor absorption could be omitted very quickly.

Flies with colon cancer help to unravel the genetic keys to disease in humans
The suppression of the gene Mirror limits tumor development in the Drosophila intestine. Credit: O Martorell, IRB Barcelona

"If there are 2000 promising molecules among a million tested in vitro, instead of testing them in mice, Drosophila could offer a good alternative to identify the two or three that are most appropriate. Both time and costs would be reduced," explains Casali.

With this aim, Casali has start collaborating with the group headed by Ernest Giralt (IRB Barcelona)—an authority on pharmacological chemistry and peptide design—to use flies to test new families of molecules against cancer.

Explore further

Fruit flies reveal features of human intestinal cancer

More information: Iro/Irx transcription factors negatively regulate Dpp/TGF-b pathway activity during intestinal tumorigenesis, Òscar Martorell, Francisco M. Barriga, Anna Merlos-Suárez, Camille Stephan-Otto Attolini, Jordi Casanova, Eduard Batlle, Elena Sancho and Andreu Casali, EMBO Reports (2014 Oct 8). DOI: 10.15252/embr.201438622

Conserved mechanisms of tumorigenesis in the Drosophila adult midgut, Òscar Martorell, Anna Merlos-Suárez, Kyra Campbell, Francisco M. Barriga, Christo P. Christov, Irene Miguel-Aliaga, Eduard Batlle, Jordi Casanova, Andreu Casali, PLoS One (2014 Feb) DOI: 10.1371/journal.pone.0088413

Journal information: EMBO Reports , PLoS ONE

Citation: Flies with colon cancer help to unravel the genetic keys to disease in humans (2014, October 8) retrieved 20 April 2021 from https://medicalxpress.com/news/2014-10-flies-colon-cancer-unravel-genetic.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments